Li YuSheng, Wang Xiao, Hu Bo, Sun Qi, Wan Mei, Carr Andrew, Liu Shen, Cao Xu
Department of Orthopedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LD, UK.
Bone Res. 2023 May 8;11(1):24. doi: 10.1038/s41413-023-00252-1.
Peritendinous adhesion formation (PAF) can substantially limit the range of motion of digits. However, the origin of myofibroblasts in PAF tissues is still unclear. In this study, we found that the concentration of active TGF-β1 and the numbers of macrophages, mesenchymal stromal cells (MSCs), and myofibroblasts in human and mouse adhesion tissues were increased. Furthermore, knockout of TGF-β1 in macrophages or TGF-β1R2 in MSCs inhibited PAF by reducing MSC and myofibroblast infiltration and collagen I and III deposition, respectively. Moreover, we found that MSCs differentiated into myofibroblasts to form adhesion tissues. Systemic injection of the TGF-β-neutralizing antibody 1D11 during the granulation formation stage of PAF significantly reduced the infiltration of MSCs and myofibroblasts and, subsequently, PAF. These results suggest that macrophage-derived TGF-β1 recruits MSCs to form myofibroblasts in peritendinous adhesions. An improved understanding of PAF mechanisms could help identify a potential therapeutic strategy.
腱周粘连形成(PAF)可显著限制手指的活动范围。然而,PAF组织中肌成纤维细胞的来源仍不清楚。在本研究中,我们发现人和小鼠粘连组织中活性转化生长因子-β1(TGF-β1)的浓度以及巨噬细胞、间充质基质细胞(MSC)和肌成纤维细胞的数量均增加。此外,巨噬细胞中TGF-β1基因敲除或MSC中TGF-β1R2基因敲除分别通过减少MSC和肌成纤维细胞浸润以及I型和III型胶原沉积来抑制PAF。此外,我们发现MSC分化为肌成纤维细胞以形成粘连组织。在PAF肉芽形成阶段全身注射TGF-β中和抗体1D11可显著减少MSC和肌成纤维细胞的浸润,进而减少PAF。这些结果表明,巨噬细胞来源的TGF-β1募集MSC以在腱周粘连中形成肌成纤维细胞。对PAF机制的深入了解有助于确定潜在的治疗策略。
Proc Natl Acad Sci U S A. 2014-11-18
Mil Med Res. 2025-8-4
Front Endocrinol (Lausanne). 2024
Adv Healthc Mater. 2025-2
Adv Sci (Weinh). 2024-10
Signal Transduct Target Ther. 2024-3-22
Bone Res. 2022-3-2
Jt Dis Relat Surg. 2020
Animal Model Exp Med. 2020-4-3
Plast Reconstr Surg. 2019-10
Transl Res. 2019-2-8